AGL 38.20 Increased By ▲ 0.05 (0.13%)
AIRLINK 129.30 Increased By ▲ 4.23 (3.38%)
BOP 7.85 Increased By ▲ 1.00 (14.6%)
CNERGY 4.66 Increased By ▲ 0.21 (4.72%)
DCL 8.35 Increased By ▲ 0.44 (5.56%)
DFML 38.86 Increased By ▲ 1.52 (4.07%)
DGKC 82.20 Increased By ▲ 4.43 (5.7%)
FCCL 33.64 Increased By ▲ 3.06 (10.01%)
FFBL 75.75 Increased By ▲ 6.89 (10.01%)
FFL 12.83 Increased By ▲ 0.97 (8.18%)
HUBC 110.72 Increased By ▲ 6.22 (5.95%)
HUMNL 14.03 Increased By ▲ 0.54 (4%)
KEL 5.22 Increased By ▲ 0.57 (12.26%)
KOSM 7.69 Increased By ▲ 0.52 (7.25%)
MLCF 40.08 Increased By ▲ 3.64 (9.99%)
NBP 72.51 Increased By ▲ 6.59 (10%)
OGDC 189.18 Increased By ▲ 9.65 (5.38%)
PAEL 25.74 Increased By ▲ 1.31 (5.36%)
PIBTL 7.38 Increased By ▲ 0.23 (3.22%)
PPL 153.45 Increased By ▲ 9.75 (6.78%)
PRL 25.52 Increased By ▲ 1.20 (4.93%)
PTC 17.92 Increased By ▲ 1.52 (9.27%)
SEARL 82.50 Increased By ▲ 3.93 (5%)
TELE 7.63 Increased By ▲ 0.41 (5.68%)
TOMCL 32.50 Increased By ▲ 0.53 (1.66%)
TPLP 8.48 Increased By ▲ 0.35 (4.31%)
TREET 16.74 Increased By ▲ 0.61 (3.78%)
TRG 56.01 Increased By ▲ 1.35 (2.47%)
UNITY 28.85 Increased By ▲ 1.35 (4.91%)
WTL 1.34 Increased By ▲ 0.05 (3.88%)
BR100 10,659 Increased By 569.2 (5.64%)
BR30 31,331 Increased By 1822.5 (6.18%)
KSE100 99,269 Increased By 4695.1 (4.96%)
KSE30 31,032 Increased By 1587.6 (5.39%)
Business & Finance GLAXO (GlaxoSmithKline Pakistan Limited) 360.00 Increased By ▲ 8.93%

GSK Consumer Health Pakistan appoints Farhan Muhammad Haroon as CEO

*The company informed that the incoming Farhan Muhammad Haroon will assume the charge of the company effective 1 April 2021.
Published February 8, 2021

The Board of Directors of Pakistan’s pharmaceutical giant, GlaxoSmithKline (GSK) Consumer Healthcare Pakistan Limited has appointed Farhan Muhammad Haroon as the Chief Executive Officer and Executive Director of the Company in place of Sohail Ahmed Matin.

“This is to inform shareholders that after an esteemed and outstanding career, Sohail Ahmed Matin will be retiring as the Chief Executive Officer of GSK Consumer Healthcare Pakistan Limited (Company) effective 31 March 2021,” said the company in a statement.

GSK informed that the incoming Farhan Muhammad Haroon will assume the charge of the company effective 1 April 2021.

“Haroon has been with GSK for over 10 years. His last assignment was Audit Account Director, of the GSK Global Audit & Assurance function. Previously Haroon also served as the Finance Director and a member of the Board of Directors of the Company,” said GSK.

“During his time with GSK, Haroon has led various key local and above country restructurings, M&As and change management projects. He has performed multiple leadership roles in Finance, Distributor Management, E2E Supply Chain, In-Country Shared Services and played key business partnering roles with Supply Chain, Legal, HR and Site operations, through which he has contributed to the success of the Company,” it added.

Comments

Comments are closed.